Wound healing studies and interfacial phenomena: Use and relevance of the corneal model

Advanced Wound Repair Therapies

Volumn , Issue , 2011, Pages 284-320

  Mann, A ^a   Tighe, B J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Biomarkers; Contact lens; Ocular surfaces; Tear film; Wound fluid

Indexed keywords

EID: 84859246126     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9780857093301.2.284     Document Type: Chapter

References (98)

1. Ahmed I.I., Breslin C.W. Role of the bandage soft contact lens in the postoperative laser in situ keratomileusis patient. J Cataract Refract Surg 2001, 27:1932-1936.
2. Asch E., Podack E. Vitronectin binds to activated human platelets and plays a role in platelet aggregation. J Clin Invest 1990, 85:1372-1378.
3. Berta A. Standardization of tear protein determinations: the effects of sampling, flow rate and vascular permeability. The Preocular Tear Film in Health, Disease, and Contact Lens Wear 1986, 418-435. Dry Eye Institute, Lubbock, TX. F.J. Holly (Ed.).
4. Broekhuyse R.M. Tear lactoferrin: A bacteriostatic complexing protein. Invest Ophthalmol Vis Sci 1974, 13:550-554.
5. Bullen E.C., Longaker M.T., Updike D.L., Benton R., Ladin D., Hou Z., Howard E.W. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 1995, 104:236-240.
6. Carter M.J., Tingley-Kelley K., Warriner R.A. Silver treatments and silver-impregnated dressings for the healing of leg wounds and ulcers: A systematic review and meta-analysis. Corrected proof, J Am Acad Dermatol 2009, 10, 1016/j. jaad.2009.09.007.
7. Cotsarelis G., Cheng S.-Z., Dong G., Sun T.-T., Lavker R. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: Implications on epithelial stem cells. Cell 1989, 57:201-209.
8. Crosson C.E., Klyce S.D., Beuerman R.W. Epithelial wound closure in the rabbit cornea. Invest Ophthalmol Vis Sci 1986, 27:464-473.
9. Cullen B., Watt P.W., Lundqvist C., Silcock D., Schmidt R.J., Bogan D., Light N.D. The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. Int J Biochem Cell Biol 2002, 34:1544-1556.
10. Cullen B., Smith R., McCulloch E., Silcock D., Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 2002, 10:16-25.
11. Cutting K.F. Wound exudate: composition and functions. Br J Community Nurs 2003, 8(9 Suppl):4-9.
12. Davis S., Gil J., Valdes J., Perez J., Rivas Y. The effects of wound dressings as barriers to Pseudomonas aeruginosa colonization of full thickness wounds using a well established porcine wound model. J Am Acad Dermatol 2009, 60(Suppl 1):AB110.
13. Declerck P.J., De Mol M., Alessi M.C., Baudner S., Paques E.P., Preissner K.T., MullerBerghaus G., Collen D. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 1988, 263:15454-15461.
14. de Souza G.A., de Godoy L.M.F., Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol 2006, 7:R72.
15. Dillman W.J., Miller I.F. On the adsorption of serum proteins on polymer membrane surfaces'. J Colloid Interface Sci 1973, 44:221-241.
16. Drinkwater S.L., Smith A., Burnand K.G. What can wound fluids tell us about the venous ulcer microenvironment?. Lower Extremity Wounds 2002, 1:184-190.
17. Dua H.S., Forrester J.V. Clinical patterns of corneal epithelial wound healing. Am J Ophthalmol 1987, 104:481-489.
18. Duncan R.L., McArthur W.P. Lactoferrin mediated modulation of mononuclear cell activities. 1. Suppression of the immune in vitro primary antibody response. Cell Immunol 1981, 63:308-320.
19. Esmaeelpour M. The effect of tear collection techniques and short-term storage on the accuracy of total tear protein. Ophthalmic Res 2004, 36:293.
20. Evans M.D.M., Sweeney D.F. Synthetic corneal implants. Biomaterials and regenerative medicine in ophthalmology 2010, 65-133. Woodhead Publishing in Materials, CRC Press Washington, DC. T. Chirila (Ed.).
21. Falanga V. Growth factors and chronic wounds: the need to understand the microenvironment. J Dermatol 1992, 19:667-672.
22. Falanga V. The chronic wound: impaired healing and solutions in the context of wound bed preparation. Blood Cells, Molecules, Diseases 2004, 32:88-94.
23. Farooqui S.Z., Foster C.S., Ma J.J.K. Central Sterile Corneal Ulceration 2008, http://www.emedicine.medscape.com/article/1196936-overview.
24. Fini M.E. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res 1999, 18:529-551.
25. Fullard R.J., Tucker D.L. Changes in human tear protein levels with progressively increasing stimulus. Invest Ophthalmol Vis Sci 1991, 32:2290-2301.
26. Gipson I.K. Adhesive mechanisms of the corneal epithelium. Acta Ophthalmol 1992, 70(s202):13-17.
27. Gleich L.L., Rebeiz E.E., Pankratov M.M., Shapshay S.M. Autologous fibrin tissue adhesive in endoscopic sinus surgery. Otolaryngol Head Neck Surg 1995, 112:238-241.
28. Gottrup F., Jørgensen B., Karlsmark T., Sibbald R.G., Rimdeika R., Harding K., Price P., Venning V., Vowden P., Jünger M., Wortmann S., Sulcaite R., Vilkevicius G., Ahokas T.-L., Ettler K., Arenbergerova M. Less pain with Biatain-Ibu: initial findings from a randomised, controlled, double-blind clinical investigation on painful venous leg ulcers. Int Wound J 2007, 4(1):24-34. Suppl.
29. Harb A., Pandya A.N. Avoiding sutured tie-over dressings on the nasal dorsum. Plastic Surg Int 2010, 2010. 2 pages.
30. Hildebrand A., Preissner K.T., Miiller-Berghaus G., Teschemacher H. A novel β-endorphin binding protein. Complement S protein (= vitronectin) exhibits specific non-opioid binding sites for β-endorphin upon interaction with heparin or surfaces. J Biol Chem 1989, 264:15429-15434.
31. Huang A.J.W., Tseng S.C.G. Corneal epithelial wound healing in the absence of limbal epithelium. Invest Ophthalmol Vis Sci 1991, 32:96-105.
32. Imanishi J., Kamiyama K., Iguchi I., Kita M., Sotozono C., Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 2000, 19:113-129.
33. James G.A., Swogger E., Wolcott R., Pulcini E., Secor P., Sestrich J., Costerton J.W., Stewart P.S. Biofilms in chronic wounds. Wound Repair Regen 2008, 16:37-44.
34. Jang Y.-C., Tsou R., Gibran N.S., Isik F.F. Vitronectin regulates wound fibrinolysis, microvascular angiogenesis and wound contraction in mice. Surgery 2000, 127:696-704.
35. Jester J.V., Petroll W.M., Cavanagh H.D. Corneal stromal wound healing in refractive surgery: The role of myofibroblasts. Prog Retin Eye Res 1999, 18:311-356.
36. Karlgard C.C.S., Jones L.W., Moresoli C. Survey of Bandage Lens Use in North America, October-December 2002. Eye Contact Lens: Sci Clin Practice 2002, 30:25-30.
37. Kijlstra A. The role of lactoferrin in the nonspecific immune response on the ocular surface. Reg Immunol 1990, 3:193-197.
38. Kijlstra A., Jeurissen S.H.M. Modulation of classical C3 covertase of complement by tear lactoferrin. Immunology 1982, 47:263-270.
39. Kuijpers T.W., Van Lier R.A., Hamann D., de Boer M., Thung L.Y., Weening R.S., Verhoeven A.J., Roos D. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest 1997, 100:1725-1733.
40. Kuwabara T., Perkins D.G., Cogan D.G. Sliding of the epithelium in experimental corneal wounds. Invest Ophthalmol 1976, 15:4-14.
41. MacCabee M.S., Trune D.R., Hwang P.H. Effects of topically applied biomaterials on paranasal sinus mucosal healing. Am J Rhinology 2003, 17:203-207.
42. Mahomed A., Tighe B.J. Structural aspects of the design of ocular drug delivery systems. CLAE 2006, 29:202.
43. Mahomed A., Cartwright H., Tighe B.J. Hydrogel release systems in ocular and dermal drug delivery. Ophthalmic Res 2003, 35:20.
44. Mann A.M., Tighe B.J. The application of counter immunoelectrophoresis (CIE) in ocular protein studies Part II: Kinin activity in the lens wearing eye. CLAE 2002, 25:81-88.
45. Mann A.M., Tighe B.J. The application of lab-on-a-chip technology in tear composition, deposited protein and tear "envelope" analysis. Ophthalmol Res 2004, 36(Suppl 1):34.
46. Mann A.M., Tighe B.J. Tear analysis and lens-tear interactions: Part I. Protein fingerprinting with microfluidic technology. CLAE 2007, 30:163-173.
47. Martin G.M., Sprague C.A., Epstein C.J. Replicative life span of cultivated human cells. Effects of donor's age, tissue and genotype. Lab Invest 1970, 23:86-92.
48. Mertz P.M., Marshall D.A., Eaglstein W.H. Occlusive wound dressings to prevent invasion and wound infection. J Am Acad Dermatol 1985, 12:662-668.
49. Mirastschijski U., Haaksma C.J., Tomasek J.J., Agren M.S. Matrix metal-loproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp Cell Res 2004, 299:465-475.
50. Muller M. Cellular senescence: molecular mechanisms, in vivo significance and redox considerations. Antiox Redox Signal 2009, 11:59-98.
51. Nishiya K., Horwitz D.D. Contrasting the effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cellmediated cytotoxicit. J Immunol 1982, 129:2519-2523.
52. Norde W. Adsorption of proteins from solution at the solid-liquid interface. Adv Colloid Interface Sci 1986, 25:267-340.
53. Norde W., Lyklema J. The adsorption of human plasma albumin and bovine pancreas ribonuclease at negatively charged polystyrene surfaces I. Adsorption isotherms. Effects of charge, ionic strength, and temperature. J Colloid Interface Sci 1978, 66:257-265.
54. Opdenakker G., Van Damme J. Cytokine-regulated proteases in autoimmune diseases. Immunol Today 1994, 15:103-107.
55. Palfreyman S., Nelson E.A., Michaels J.A. Dressings for venous leg ulcers: systematic review and meta-analysis. BMJ 2007, 335. 12 pages. 10.1136/bmj.39322.685405.AD.
56. Peach H.C., Mann A.M., Tighe B.J. Immunoblotting and tear sampling techniques for the study of contact lens-induced variations in tear protein profiles. Adv Expt Med Bio 2002, 506:967-971.
57. Pfister R.R. Corneal stem cell disease: Concepts, categorization, and treatment by auto-and homotransplantation of limbal stem cells. CLAO J 1994, 20:64-72.
58. Pitt W.G., Cooper S.L. Albumin adsorption on alkyl chain derivatized polyurethanes: I. The effect of C-18 alkylation. J Biomed Mater Res 1988, 22:359-382.
59. Preissner K.T., Seiffert D. Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res 1998, 89:1-21.
60. Princz M.A., Sheardown H., Griffith M. Corneal tissue engineering and versus synthetic artifical corneas'. Biomaterials and regenerative medicine in ophthalmology 2010, 65-133. Woodhead Publishing in Materials, CRC Press Washington, DC. T. Chirila (Ed.).
61. Pytela R., Pierschbacher M.D., Ruoslahti E. Identification and isolation of a 140kDa cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 1985, 40:191-198.
62. Sack R.A., Tan K.O., Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Ophthalmol Vis Sci 1992, 33:626-640.
63. Sack R.A., Underwood P.A., Tan K.O., Sutherland H., Morris C.A. Vitronectin. Ocular Immumol Inflamm 1993, 1:327-336.
64. Salonen E.M., Tervo T., Torma E., Tarkkanen A., Vaheri A. Plasmin in tear fluid of patients with corneal ulsers: Basis for new therapy. Acta Ophthalmol 1987, 65:3-12.
65. Schermer A., Galvin S., Sun T.T. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol 1986, 103:49-62.
66. Schneider E.L., Mutsui Y. 'The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci 1976, 73:3584-3588.
67. Schönfelder U., Abel M., Wiegand C., Klemm D., Elsner P., Hipler U.-C. Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential in vitro. Biomaterials 2005, 26:6664-6673.
68. Sergio D., Rosenzweig M.D., Holland S.M. Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol 2004, 113:620-626.
69. Shai A., Maibach H.I. Wound healing and ulcers of the skin. Diagnosis and therapy - the practical approach 2005, 14-15. Springer-Verlag, Berlin Heidelburg.
70. Shelton D.N., Chang E., Whittier P.S., Choi D., Funk W.D. 'Microarray analysis of replicative senescence. Curr Biol 1999, 9:939-945.
71. Soldati D., Rahm F., Pasche P. Mucosal wound healing after nasal surgery. A controlled clinical trial on the efficacy of hyaluronic acid containing cream. Drugs Exp Clin Res 1999, 25:253-261.
72. Stashak T.S., Frastevedt E., Othic A. Update on wound dressings: Indications and best use. Clin Tech Equine Prac 2004, 3:148-163.
73. Stuchell R.N., Feldman J.J., Farris R.L., Mandel I.D. The effect of collection technique on tear composition. Invest Ophthalmol Vis Sci 1984, 25:374-377.
74. Suda T., Nishida T., Ohashi Y., Nakagawa S., Manabe R. Fibronectin appears at the site of corneal stroma wounds in rabbits. Curr Eye Res 1981-1982, 1:553-556.
75. Sundaram S., Lim F., Cooper S.L., Colman R.W. Role of leucocytes in coagulation induced by artificial surfaces: investigation of expression of MAC-1, granulocyte elastase and leucocyte adhesion on modified polyurethanes. Biomaterials 1996, 17:1041-1047.
76. Szpaderska A.M., Zuckerman J.D., DiPietro L.A. Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res 2003, 82:621-626.
77. Tausche A.-K., Sebastian G. 'Wound conditioning of a deep tissue defect including exposed bone after tumour excision using PROMOGRAN Matrix, a protease-modulating matrix. Int Wound J 2005, 2:253-257.
78. Telfer N.R., Moy R.L. Wound care after office procedures. J Dermatol Surg Oncol 1993, 19:722-731.
79. Tervo T., Salonen E.M., Vaheri A., Immonen I., Van Setten G.B., Himberg J.J., Tarkkanen Elevation of tear plasmin in corneal disease. Acta Ophthalmol 1988, 66:393-399.
80. Thiagarajan P., Kelly K.L. Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem 1988, 263:3035-3038.
81. Thoft R.A., Friend J. The X, Y, Z hypothesis of corneal epithelial maintenance. Invest Ophthamol Vis Sci 1983, 24:1442-1443.
82. Tighe B.J., Franklin V.J., Graham C., Mann A., Guillon M. Ophthalmic biomaterials: the inflammatory role of vitronectin. Anales Del Instituto Barraquer 2001, XXX:221-222.
83. Trengove N.J., Langton S.R., Stacey M.C. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 1996, 4:234-239.
84. Trengove N.J., Stacey M.C., MacAuley S., Bennett N., Gibson J., Burslem F., Murphy G., Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999, 7:442-452.
85. Tuominen I.S., Tervo T.M., Teppo A.M., Valle T.U., Gronhagen-Riska C., Vesaluoma M.H. Human tear fluid PDGF-BB, TNF-alpha and TGF-beta 1 vs. corneal haze and regeneration of corneal epithelium and sub-basal nerve plexus after PRK. Exp Eye Res 2001, 72:631-641.
86. Vaheri A., Bizik J., Salonen E.M., Tapiovaara H., Siren V., Myohanen H., Stephens R.W. Regulation of the pericellular activation of plasminogen and its role in tissue-destructive process. Act Ophthalmol 1992, 70:34-41.
87. Valentine R., Wormald P.-J. Nasal dressings after endoscopic sinus surgery: what and why?. Curr Opin Otolaryngology Head Neck Surg 2010, 18:44-48.
88. Valleala H., Hanemaaijer R., Mandelin J., Salminen A., Teronen O., Monkkonen J., Konttinen Y.T. Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates. Life Sciences 2003, 73:2413-2420.
89. Vannas A., Sweeney D.F., Holden B.A., Sapyska E., Salonen E.M., Vaheri A. Tear plasmin activity with contact lens wear. Curr Eye Res 1992, 11:245-251.
90. Venter T.H.J., Karpelowsky J.S., Rodeburns H. Cooling of the burn wound: The ideal temperature of the coolant. Burns 2007, 33:917-922.
91. Vermeulen H., Westerbos S.J., Ubbink D.T. Benefit and harm of iodine in wound care: a systematic review. J Hosp Inf, Corrected Proof 2010, 10. 1016/j. jhin.2010.04.026.
92. Vroman L. Effect of adsorbed proteins on the wettability of hydrophilic and hydrophobic solids. Nature 1962, 196:476-477.
93. Wahlgren M., Arnebrant T. Protein adsorption to solid surfaces. Trends in Biotech 1991, 9:201-208.
94. Wilson S.E., Liu J.J., Mohan R.R. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res 1999, 18:293-309.
95. Wilson S.E., Mohan R.R., Ambrosio R., Hong J., Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Reti Eye Res 2001, 20:625-637.
96. Yager D.R., Nwomeh B.C. The proteolytic environment of chronic wounds. Wound Repair Regen 1999, 7:433-441.
97. Yu F-S X., Yin J., Xu K., Huang J. Growth factors and corneal epithelial wound healing. Brain Res Bulletin 2010, 81:229-235.
98. Zavaro A., Samra Z., Baryishak R., Sompolinsky D. Proteins in tears from healthy and diseased eye. Documenta Ophthalmologica 1980, 50:185-199.